期刊文献+

Effects of quadruple antituberculous drugs in combination with linezolid and moxifloxacin on CSF cytology, NSE, NGF and its receptors in patients with refractory tuberculous meningitis

下载PDF
导出
摘要 Objective: To investigate the effects of linezolid and moxifloxacin combined with quadruple antituberculosis drugs on CSF cytology, NSE (neuronal specific enolase), NGF(nerve growth facor) and its receptors, endothelin and its receptors and CRP (C reaction protein) in patients with refractory tuberculous meningitis. Method: A total of 56 patients were selected with tuberculous meningitis in our hospital from February 2014 to December 2017,randomly divided them into 2 groups, each group was 28 cases, set as the observation group and the control group, both groups were treated with quadruple antituberculosis drugs, the observation group was given ilinezolid on this basis, and the control group was combined with moxifloxacin, The course of treatment was 4 weeks, compared the levels of CSF cytology, NSE, NGF and NGF receptors, endothelin and endothelin receptors, and CRP after treatment in the two groups. Result:The CSF cytology, NSE, NGF and NGF receptors, endothelin and endothelin receptor, and CRP levels remained unchanged before treatment, the difference was not statistically significant. After treatment, the chloride and glucose levels in the observation group were higher than those before treatment and that of the control group, the protein, white blood cell count, and cerebrospinal fluid pressure levels were lower than before treatment and that of the control group, the difference was statistically significant;The NSE level in the observation group after treatment was lower than before treatment and that of the control group, the difference was statistically significant;After treatment, the levels of NGF and its receptors in the observation group were higher than those before treatment and that of the control group, and the levels of endothelin, and its receptor, CRP were lower than those before treatment and that of the control group, the difference was statistically significant. Conclusion:The use of linezolid in combination with quadruple antituberculosis drugs to treat refractory tuberculous meningitis has better clinical effect, effectively improve cerebrospinal fluid cytology, regulate cerebrospinal fluid NSE levels, restore NGF, endothelin and its receptor function, reduce inflammatory response, recommended for clinical promotion and application.
出处 《Journal of Hainan Medical University》 2018年第15期44-47,共4页 海南医学院学报(英文版)
  • 相关文献

参考文献3

二级参考文献33

  • 1Tsai TN, Wu CP, Peng MY, et al. Short course of linezolid treatment for Vaneomyein-resistant Enterococcus faecium meningitis[J]. Int J Clin Pract, 2006,60 : 740-741.
  • 2Kruse AJ, Peerdeman SM, Bet PM, et al. Successful Treat- ment with linezolid and rifamplcin of meningitis due to methicillin-resistant Staphylococcus epidermidis refractory to Vancomycin treatment[J]. Eur J Clin Microbiol Infect Dis, 2006,25:135-137.
  • 3Kallweit U,Harzheim M,Marklein G,et al. Successful treatment of methicillin-resistant Staphylococcus aureus meningitis using linezolid without removal of intrathecal infusion pump. Case report[J]. J Neurosurg,2007,107:651-653.
  • 4Marx GE,Chan ED. Tuberculous meningitis:diagnosis and treatment overview[J].Tuberc Res Treat,2011.798764.
  • 5Bidstrup C,Andersen PH,Skinhoj P. Tuberculous meningitis in a country with a low incidence of tuberculosis:still a serious disease and a diagnostic challenge[J].{H}SCANDINAVIAN Journal OF INFECTIOUS DISEASES,2002,(11):811-814.
  • 6Stop TB. Department of World Health Organization.Treatment of tuberculosis guidelines[A].www.who.int/tb,.
  • 7Anne-Sophie H Christensen,Ase B Andersen,Vibeke Thomsen. Tuberculous meningitis in Denmark:a review of 50 cases[J].{H}BMC Infectious Diseases,2011.47.
  • 8Rodriguez JC,Ruiz M,Lopez M. In vitro activity of moxifloxacin,levofloxacin,gatifloxacin and linezolid against Mycobacterium tuberculosis[J].{H}International Journal of Antimicrobial Agents,2002,(06):464-467.
  • 9Alffenaar JWC,van Altena R,Bokkerink HJ. Pharmacokinetics of moxifloxacinin cerebrospinal fluid and plasma in patients with tuberculous meningitis[J].{H}Clinical Infectious Diseases,2009.1080-1082.
  • 10Pranger AD,van Altena R,Aarnoutse RE. Evaluation of moxifloxacin for the treatment of tuberculosis:3 years of experience[J].{H}European Respiratory Journal,2011.888-894.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部